Soleus Capital Management, L.P. Alpine Immune Sciences, Inc. Transaction History

Soleus Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$6.84 - $11.91 $602,419 - $1.05 Million	88,073 New	88,073 $905,000
Q2 2021 Aug 16, 2021	SELL	$8.81 - $15.03 $2.76 Million - $4.71 Million	-313,064 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.02 - $13.92 $2.73 Million - $3.79 Million	272,000 Added 662.38%	313,064 $3.32 Million
Q4 2020 Feb 16, 2021	BUY	$7.42 - $15.96 $304,694 - $655,381	41,064 New	41,064 $517,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.